Versor Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Buy |
+8,012
| New | +$371K | 0.07% | 477 |
|
|
2025
Q1 | – | Sell |
-21,208
| Closed | -$1.2M | – | 719 |
|
|
2024
Q4 | $1.2M | Sell |
21,208
-2,592
| -11% | -$147K | 0.21% | 109 |
|
|
2024
Q3 | $1.23M | Buy |
23,800
+2,900
| +14% | +$150K | 0.19% | 137 |
|
|
2024
Q2 | $868K | Buy |
+20,900
| New | +$868K | 0.16% | 184 |
|
|
2024
Q1 | – | Sell |
-13,600
| Closed | -$698K | – | 693 |
|
|
2023
Q4 | $698K | Buy |
13,600
+1,870
| +16% | +$96K | 0.14% | 228 |
|
|
2023
Q3 | $681K | Buy |
+11,730
| New | +$681K | 0.14% | 208 |
|
|
2022
Q4 | – | Sell |
-30,579
| Closed | -$2.17M | – | 736 |
|
|
2022
Q3 | $2.17M | Sell |
30,579
-7,245
| -19% | -$515K | 0.13% | 74 |
|
|
2022
Q2 | $2.91M | Buy |
37,824
+34,273
| +965% | +$2.64M | 0.11% | 61 |
|
|
2022
Q1 | $259K | Buy |
+3,551
| New | +$259K | 0.01% | 524 |
|
|
2021
Q3 | – | Sell |
-5,907
| Closed | -$395K | – | 511 |
|
|
2021
Q2 | $395K | Sell |
5,907
-2,186
| -27% | -$146K | 0.01% | 189 |
|
|
2021
Q1 | $511K | Buy |
8,093
+300
| +4% | +$18.9K | 0.03% | 131 |
|
|
2020
Q4 | $483K | Sell |
7,793
-10,061
| -56% | -$624K | 0.04% | 41 |
|
|
2020
Q3 | $1.08M | Sell |
17,854
-1,200
| -6% | -$72.3K | 0.09% | 68 |
|
|
2020
Q2 | $1.12M | Buy |
+19,054
| New | +$1.12M | 0.11% | 23 |
|
|
2019
Q1 | – | Sell |
-10,520
| Closed | -$547K | – | 275 |
|
|
2018
Q4 | $547K | Sell |
10,520
-9,980
| -49% | -$519K | 0.13% | 149 |
|
|
2018
Q3 | $1.27M | Buy |
+20,500
| New | +$1.27M | 0.48% | 64 |
|